In other words, the overexpression of sPD-1 can prevent the T cell inhibition by blocking sPD-L1/mPD-L1 signaling, while the overexpression of sPD-L1 can inhibit T cell activation, supporting cancer immune evasion. Here, HOXD13 is linked to cancer.